Malignant Hyperthermia (MH) is a rare, hereditary, life-threatening disease triggered by
volatile anesthetics and succinylcholine. Rarely, MH can occur after non-pharmacological …

INTRODUCTION Malignant hyperthermia (MH) is an uncommon and potentially
lifethreatening genetically based disorder of skeletal muscle that occurs in susceptible …

Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle that presents
as a hypermetabolic response to potent volatile anesthetic gases such as halothane …

Malignant hyperthermia (MH) is a rare, potentially lethal disorder of skeletal muscle. MH-
susceptible persons may acquire fulminant hypermetabolism and muscle injury when …

Malignant hyperthermia (MH) is an autosomal dominant skeletal muscle disorder,
associated with life threatening skeletal muscle hypermetabolism upon exposure to …

This issue of Anesthesia & Analgesia brings together a collection of papers focused on the
prevalence of malignant hyperthermia (MH), the possible association of exertional heat …

Malignant hyperthermia (MH) is a rare autosomal dominant trait that predisposes individuals
to great danger when exposed to certain anaesthetic triggering agents, such as potent …

BACKGROUND: Malignant hyperthermia (MH) is an inherited muscle disorder induced by
volatile anesthetics and depolarizing muscle relaxants. While the incidence of MH is high in …

In one form or another, the following scenario is occurring daily in hospitals throughout the
world: a 10-mo-old infant with progressive hypotonia and failure to thrive is scheduled for a …

Malignant Hyperthermia in a Three-Month-Old American Indian Infant Page 1 ANESTH
ANALG 1043 1987;66: 1043-5 Malignant Hyperthermia in a Three-Month-Old American …